Canaccord Genuity Group Increases Boston Scientific (NYSE:BSX) Price Target to $88.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective upped by Canaccord Genuity Group from $83.00 to $88.00 in a research report released on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical equipment provider’s stock. BSX has been the subject of a number of other reports. UBS […]
More Stories
Sudan crisis must not be forgotten by world leaders, says UN food agency
Ongoing heavy fighting in Sudan has continued to kill and uproot the country’s people who global leaders should remember as...
US Plans to Bring Attempted Assassination Charge Against Ryan Routh
By Jack Phillips and T.J. Muscaro WEST PALM BEACH, Fla.—Federal prosecutors are looking to bring a charge of attempted assassination...
China, Iran, Russia Using AI to Influence US Elections, Intelligence Community Warns
By Tom Ozimek Foreign powers are increasingly using artificial intelligence (AI) to influence how Americans vote, according to a new...
Tia Hernlen: The 5-Year-Old Kid Known For Bravery
On March 28, 2005, Tia Hernlen, a 5-year-old from New Smyrna Beach, Florida, made headlines with a traumatizing telephonic conversation...
Wintrust Financial Co. (NASDAQ:WTFC) Receives Consensus Rating of “Moderate Buy” from Brokerages
Shares of Wintrust Financial Co. (NASDAQ:WTFC – Get Free Report) have earned an average rating of “Moderate Buy” from the...
Khloe Kardashian Revealed Shocking Details in KUWTK Clip
Amid Sean Diddy Combs’s arrest for sexual trafficking and assault, a decade-old clip from Keeping Up With Kardashians has now...